Allergan Strikes $200M Deal To Exit NY Opioid Trial

By Cara Salvatore · December 8, 2021, 11:11 AM EST

Allergan has reached a settlement worth up to $200 million to end its participation in a closely watched New York opioid trial brought by state and county governments, according to a Wednesday announcement....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

1:17-md-02804

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022